ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 143 participants.
Also called NCT05988411
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 143 participants
- Sponsor
- Registry
-
NCT05988411
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05988411. Randomized; single masking; primary purpose treatment. Start 2023-12-07 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Renal Denervation
- Intervention (Device)
- Catheter Ablation
- Lead sponsor
- Vivek Reddy
Record details
- Record id
cardio:ct-nct05988411- Content hash
e3d4a31960bd77a6633e47c165f349abae90425408a746acf8dab05a09d307dc